Fertilizers · Founded 1961 · www.coromandel.biz · BSE 506395 · NSE COROM INTER · ISIN INE169A01031
No Notes Added Yet
Business
Coromandel International Ltd. is a leading Indian agricultural inputs company. Its core business involves the manufacturing and marketing of a comprehensive range of plant nutrition solutions. This primarily includes phosphatic fertilizers (such as DAP and NPK complexes), single super phosphate (SSP), specialty nutrients (e.g., micronutrients, water-soluble fertilizers), crop protection products (insecticides, fungicides, herbicides), and organic fertilizers. The company operates through a robust sales and distribution network across India, catering to farmers directly and through dealers, making money by selling these essential agricultural inputs. It also has a farm retail business ("Mana Gromor" centers) providing farm advisory services and a range of agricultural products.
Revenue Mix
Coromandel International's primary segments are:
Nutrient & Allied Businesses: This is the largest segment, encompassing phosphatic fertilizers (Complex Fertilizers like DAP, NPKs), Single Super Phosphate (SSP), Specialty Nutrients, and Organic Fertilizers.
Crop Protection Business: This segment includes the manufacturing and marketing of insecticides, fungicides, herbicides, and plant growth regulators.
Retail Business: Through its 'Mana Gromor' centers, Coromandel offers a one-stop solution for farmers, providing fertilizers, crop protection products, seeds, and farm advisory services.
While exact revenue percentages fluctuate, the Nutrient & Allied Businesses segment typically accounts for the majority of the company's revenue.
Industry
Coromandel operates in the Indian agricultural inputs industry, which is characterized by its essential nature, dependence on monsoons, and significant government regulation and subsidies, especially for fertilizers. The industry is moderately consolidated with a few large domestic players. Coromandel is a prominent and well-established player, particularly strong in phosphatic fertilizers (often ranking among the top 2-3 manufacturers in India for complex fertilizers). It benefits from an extensive distribution network, brand recognition among farmers, and a diversified product portfolio that extends beyond core fertilizers into crop protection and specialty nutrients.
MOAT
Coromandel possesses several durable advantages:
Scale and Integrated Operations: Large manufacturing capacities for phosphatic fertilizers and backward integration into key raw materials (like phosphoric acid production) provide cost efficiencies and supply chain stability.
Extensive Distribution Network: A strong, well-entrenched network of dealers and rural retail outlets (Mana Gromor centers) provides wide market reach across agricultural regions of India.
Brand Recognition: Established brand loyalty and trust among Indian farmers built over decades.
Product Diversification: A broad portfolio spanning fertilizers, specialty nutrients, and crop protection reduces reliance on a single product category and caters to varied farmer needs.
R&D Capabilities: Focus on developing new formulations and customized nutrient solutions.
Growth Drivers
Increasing Agricultural Demand: Driven by India's growing population and the continuous need for food security, leading to sustained demand for agricultural inputs.
Government Support for Agriculture: Continued policy focus on enhancing farm productivity and farmer income, including fertilizer subsidies and irrigation projects.
Product Portfolio Expansion: Growth in specialty nutrients, organic fertilizers, and biologicals, which are gaining traction for improving soil health and crop yields.
Rural Retail Expansion: Widening the reach of 'Mana Gromor' centers to provide integrated farm solutions and drive direct engagement with farmers.
Improved Farming Practices: Adoption of balanced nutrition and modern agricultural techniques by farmers, driving demand for diversified products.
Risks
Government Policy and Subsidies: High dependence on government policies regarding fertilizer pricing, subsidies, and payment timelines, which can impact profitability and working capital.
Raw Material Price Volatility: Significant exposure to global price fluctuations of key imported raw materials like rock phosphate, sulfur, ammonia, and natural gas.
Monsoon Dependency: Agricultural output and, consequently, demand for inputs are heavily reliant on the regularity and adequacy of the monsoon.
Regulatory Environment: Changes in environmental regulations or import duties can impact operations and costs.
Competition: Intense competition from both domestic and international players in various product segments.
Currency Fluctuations: Exposure to foreign exchange rate volatility due to significant raw material imports.
Management & Ownership
Coromandel International Ltd. is part of the Murugappa Group, a respected and diversified Indian conglomerate. The Murugappa Group acts as the promoter, holding a significant ownership stake. The company is generally perceived to have professional management with a strong track record in the fertilizer and agrochemical industry. The long-standing presence of the Murugappa Group provides stability and a focus on long-term sustainable growth.
Outlook
Coromandel International is positioned as a resilient player in the essential Indian agricultural inputs sector. The bull case rests on India's consistent agricultural demand, the company's strong market leadership in key segments, its diversified product portfolio providing multiple growth avenues (especially in specialty nutrients and crop protection), and its integrated operations that offer cost advantages. The widespread distribution network and farmer trust further solidify its position.
However, the bear case highlights the inherent volatility and risks associated with the sector. High dependence on government fertilizer subsidies introduces policy and receivables risk. Global raw material price fluctuations can compress margins, and the vagaries of the Indian monsoon directly impact demand. Intense competition and evolving regulatory landscapes also present ongoing challenges. Overall, Coromandel presents a stable, fundamentally strong business with growth potential, albeit within a sensitive and regulated industry.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 5464 | 3913 | 4729 | 7433 | 6935 | 4988 | 7042 | 9654 | 8779 | 6004 |
| Other Income | 59 | 84 | 54 | 65 | 114 | 126 | 84 | 116 | 83 | 65 |
| Total Income | 5523 | 3996 | 4783 | 7498 | 7049 | 5114 | 7126 | 9771 | 8863 | 6068 |
| Total Expenditure | 5106 | 3640 | 4223 | 6458 | 6213 | 4562 | 6260 | 8508 | 7980 | 5516 |
| Operating Profit | 416 | 357 | 560 | 1040 | 835 | 552 | 866 | 1263 | 883 | 552 |
| Interest | 38 | 62 | 57 | 66 | 73 | 66 | 68 | 102 | 84 | 89 |
| Depreciation | 64 | 63 | 65 | 69 | 71 | 85 | 121 | 102 | 147 | 165 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 347 | 0 | 0 | 0 | -71 |
| Profit Before Tax | 315 | 232 | 437 | 905 | 692 | 747 | 677 | 1059 | 653 | 228 |
| Provision for Tax | 78 | 58 | 113 | 233 | 175 | 152 | 176 | 266 | 164 | 113 |
| Profit After Tax | 237 | 174 | 325 | 672 | 516 | 595 | 502 | 793 | 488 | 115 |
| Adjustments | -6 | -14 | -14 | -8 | -5 | -15 | 3 | 12 | 17 | 25 |
| Profit After Adjustments | 231 | 160 | 311 | 664 | 512 | 580 | 505 | 805 | 506 | 140 |
| Adjusted Earnings Per Share | 7.8 | 5.4 | 10.6 | 22.5 | 17.4 | 19.7 | 17.1 | 27.3 | 17.1 | 4.7 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 11306 | 11481 | 10031 | 11083 | 13225 | 13137 | 14182 | 19111 | 29628 | 22058 | 24085 | 31479 |
| Other Income | 57 | 66 | 55 | 60 | 37 | 40 | 75 | 144 | 171 | 231 | 359 | 348 |
| Total Income | 11363 | 11548 | 10086 | 11143 | 13262 | 13177 | 14257 | 19255 | 29799 | 22290 | 24444 | 31828 |
| Total Expenditure | 10453 | 10715 | 9048 | 9826 | 11782 | 11406 | 12198 | 16961 | 26702 | 19660 | 21457 | 28264 |
| Operating Profit | 910 | 833 | 1038 | 1316 | 1480 | 1771 | 2059 | 2294 | 3097 | 2630 | 2987 | 3564 |
| Interest | 210 | 221 | 224 | 178 | 251 | 235 | 106 | 75 | 190 | 187 | 262 | 343 |
| Depreciation | 105 | 106 | 101 | 99 | 114 | 158 | 173 | 173 | 182 | 229 | 290 | 535 |
| Exceptional Income / Expenses | -4 | 25 | 0 | 0 | -24 | 0 | 0 | 0 | 0 | 0 | 347 | -71 |
| Profit Before Tax | 592 | 529 | 712 | 1038 | 1093 | 1379 | 1786 | 2050 | 2701 | 2188 | 2728 | 2617 |
| Provision for Tax | 190 | 172 | 235 | 347 | 372 | 313 | 457 | 521 | 688 | 548 | 673 | 719 |
| Profit After Tax | 402 | 357 | 477 | 691 | 720 | 1065 | 1329 | 1528 | 2013 | 1641 | 2055 | 1898 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 12 | 57 |
| Profit After Adjustments | 402 | 357 | 477 | 691 | 720 | 1065 | 1329 | 1528 | 2013 | 1642 | 2066 | 1956 |
| Adjusted Earnings Per Share | 13.8 | 12.3 | 16.4 | 23.6 | 24.6 | 36.3 | 45.3 | 52.1 | 68.5 | 55.8 | 70.1 | 66.2 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 9% | 8% | 13% | 8% |
| Operating Profit CAGR | 14% | 9% | 11% | 13% |
| PAT CAGR | 25% | 10% | 14% | 18% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -23% | 23% | 17% | 22% |
| ROE Average | 20% | 22% | 24% | 22% |
| ROCE Average | 29% | 32% | 34% | 26% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 2202 | 2634 | 2891 | 2896 | 3358 | 4318 | 5151 | 6358 | 7908 | 9420 | 11088 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27 | 135 |
| Borrowings | 67 | 44 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 85 |
| Other Non-Current Liabilities | 234 | 198 | 175 | 151 | 137 | 465 | 443 | 461 | 471 | 535 | 619 |
| Total Current Liabilities | 5859 | 6306 | 5579 | 6801 | 7079 | 5367 | 3302 | 4466 | 5857 | 5864 | 6990 |
| Total Liabilities | 8362 | 9182 | 8645 | 9848 | 10574 | 10149 | 8895 | 11285 | 14235 | 15845 | 18917 |
| Fixed Assets | 1380 | 1320 | 1328 | 1327 | 1309 | 2032 | 2015 | 2092 | 2200 | 3112 | 4139 |
| Other Non-Current Assets | 467 | 615 | 481 | 359 | 512 | 323 | 359 | 853 | 1791 | 617 | 1547 |
| Total Current Assets | 6515 | 7247 | 6837 | 8162 | 8753 | 7794 | 6521 | 8340 | 10244 | 12116 | 13231 |
| Total Assets | 8362 | 9182 | 8645 | 9848 | 10574 | 10149 | 8895 | 11285 | 14235 | 15845 | 18917 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 410 | 209 | 174 | 147 | 447 | 132 | 51 | 692 | 706 | 1400 | 1127 |
| Cash Flow from Operating Activities | 86 | 18 | 915 | 263 | 526 | 1862 | 4150 | 2078 | 591 | 1428 | 2464 |
| Cash Flow from Investing Activities | -216 | -61 | -79 | 32 | -597 | -222 | -1257 | -1622 | 639 | -1338 | -2638 |
| Cash Flow from Financing Activities | -64 | 8 | -864 | -1 | -244 | -1723 | -2263 | -443 | -543 | -363 | -698 |
| Net Cash Inflow / Outflow | -194 | -35 | -28 | 294 | -315 | -83 | 630 | 14 | 687 | -274 | -872 |
| Closing Cash & Cash Equivalent | 217 | 174 | 147 | 447 | 132 | 51 | 692 | 706 | 1394 | 1127 | 255 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 13.79 | 12.27 | 16.35 | 23.64 | 24.63 | 36.35 | 45.3 | 52.08 | 68.47 | 55.78 | 70.14 |
| CEPS(Rs) | 17.38 | 15.91 | 19.8 | 27.03 | 28.52 | 41.74 | 51.2 | 57.96 | 74.66 | 63.49 | 79.6 |
| DPS(Rs) | 4.5 | 4 | 5 | 6.5 | 6.5 | 12 | 12 | 12 | 12 | 6 | 15 |
| Book NAV/Share(Rs) | 75.59 | 90.4 | 99.02 | 98.74 | 114.32 | 146.94 | 175.17 | 216.22 | 268.55 | 319.54 | 375.77 |
| Core EBITDA Margin(%) | 7.44 | 6.59 | 9.64 | 11.29 | 10.91 | 13.18 | 13.99 | 11.25 | 9.88 | 10.87 | 10.91 |
| EBIT Margin(%) | 6.98 | 6.45 | 9.18 | 10.93 | 10.16 | 12.28 | 13.34 | 11.12 | 9.76 | 10.77 | 12.41 |
| Pre Tax Margin(%) | 5.16 | 4.55 | 6.99 | 9.33 | 8.26 | 10.49 | 12.59 | 10.73 | 9.12 | 9.92 | 11.32 |
| PAT Margin (%) | 3.5 | 3.07 | 4.68 | 6.21 | 5.45 | 8.11 | 9.37 | 8 | 6.79 | 7.44 | 8.53 |
| Cash Profit Margin (%) | 4.41 | 3.98 | 5.67 | 7.1 | 6.31 | 9.31 | 10.59 | 8.9 | 7.41 | 8.47 | 9.74 |
| ROA(%) | 5.03 | 4.07 | 5.35 | 7.48 | 7.06 | 10.28 | 13.96 | 15.15 | 15.78 | 10.91 | 11.82 |
| ROE(%) | 17.93 | 14.78 | 17.28 | 23.94 | 23.13 | 27.85 | 28.15 | 26.62 | 28.27 | 18.96 | 20.07 |
| ROCE(%) | 18.61 | 15.31 | 17.95 | 22.64 | 22.51 | 26.34 | 34.1 | 36.93 | 40.51 | 27.32 | 28.76 |
| Receivable days | 46.59 | 48.45 | 58.42 | 52.47 | 46.95 | 49.44 | 29.45 | 7.82 | 5.26 | 16.4 | 19.87 |
| Inventory Days | 63.8 | 72.24 | 72.86 | 65.39 | 75.95 | 82.5 | 68.18 | 59.82 | 49.77 | 74.7 | 71.09 |
| Payable days | 57.85 | 50.87 | 51.81 | 52.95 | 46.66 | 76.93 | 84.88 | 49.82 | 32.01 | 42.08 | 43.04 |
| PER(x) | 19.46 | 15.48 | 19.13 | 22.15 | 20.27 | 14.96 | 17.09 | 15.35 | 12.84 | 19.29 | 28.23 |
| Price/Book(x) | 3.55 | 2.1 | 3.16 | 5.3 | 4.37 | 3.7 | 4.42 | 3.7 | 3.27 | 3.37 | 5.27 |
| Dividend Yield(%) | 1.68 | 2.11 | 1.6 | 1.24 | 1.3 | 2.21 | 1.55 | 1.5 | 1.36 | 0.56 | 0.76 |
| EV/Net Sales(x) | 0.87 | 0.7 | 1.12 | 1.58 | 1.32 | 1.33 | 1.55 | 1.14 | 0.82 | 1.3 | 2.28 |
| EV/Core EBITDA(x) | 10.76 | 9.61 | 10.78 | 13.29 | 11.76 | 9.87 | 10.68 | 9.46 | 7.89 | 10.93 | 18.42 |
| Net Sales Growth(%) | 12.47 | 1.55 | -12.63 | 10.49 | 19.32 | -0.66 | 7.96 | 34.75 | 55.03 | -25.55 | 9.19 |
| EBIT Growth(%) | 5.84 | -6.43 | 24.81 | 29.95 | 10.43 | 20.14 | 17.22 | 12.35 | 36.03 | -17.84 | 25.89 |
| PAT Growth(%) | 10.1 | -11.04 | 33.44 | 44.94 | 4.22 | 47.82 | 24.8 | 15 | 31.7 | -18.49 | 25.24 |
| EPS Growth(%) | 9.67 | -11.04 | 33.25 | 44.59 | 4.18 | 47.57 | 24.63 | 14.96 | 31.47 | -18.53 | 25.75 |
| Debt/Equity(x) | 1.04 | 1.02 | 0.77 | 0.95 | 0.88 | 0.38 | 0 | 0 | 0 | 0.01 | 0.02 |
| Current Ratio(x) | 1.11 | 1.15 | 1.23 | 1.2 | 1.24 | 1.45 | 1.98 | 1.87 | 1.75 | 2.07 | 1.89 |
| Quick Ratio(x) | 0.73 | 0.78 | 0.92 | 0.87 | 0.78 | 0.95 | 1.19 | 1.05 | 1 | 1.28 | 1.21 |
| Interest Cover(x) | 3.82 | 3.39 | 4.18 | 6.82 | 5.36 | 6.86 | 17.9 | 28.16 | 15.21 | 12.73 | 11.39 |
| Total Debt/Mcap(x) | 0.29 | 0.48 | 0.24 | 0.18 | 0.2 | 0.1 | 0 | 0 | 0 | 0 | 0 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 57.33 | 57.32 | 57.31 | 57.17 | 56.97 | 56.96 | 56.9 | 56.88 | 56.86 | 56.35 |
| FII | 7.71 | 7.34 | 7.51 | 7.79 | 8.33 | 10.61 | 14.28 | 14.51 | 13.8 | 13.02 |
| DII | 20.22 | 20.64 | 20.79 | 21.23 | 21 | 18.96 | 15.84 | 15.76 | 16.67 | 18.18 |
| Public | 14.74 | 14.7 | 14.38 | 13.81 | 13.71 | 13.47 | 12.97 | 12.85 | 12.67 | 12.45 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 16.88 | 16.88 | 16.88 | 16.84 | 16.78 | 16.78 | 16.78 | 16.77 | 16.77 | 16.62 |
| FII | 2.27 | 2.16 | 2.21 | 2.29 | 2.45 | 3.13 | 4.21 | 4.28 | 4.07 | 3.84 |
| DII | 5.95 | 6.08 | 6.12 | 6.25 | 6.19 | 5.59 | 4.67 | 4.65 | 4.92 | 5.36 |
| Public | 4.34 | 4.33 | 4.24 | 4.07 | 4.04 | 3.97 | 3.82 | 3.79 | 3.74 | 3.67 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 29.44 | 29.44 | 29.45 | 29.45 | 29.46 | 29.46 | 29.48 | 29.49 | 29.5 | 29.5 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +9% | +8% | +13% | +8% |
| Operating Profit CAGR | +14% | +9% | +11% | +13% |
| PAT CAGR | +25% | +10% | +14% | +18% |
| Share Price CAGR | -23% | +23% | +17% | +22% |
| ROE Average | +20% | +22% | +24% | +22% |
| ROCE Average | +29% | +32% | +34% | +26% |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 57.33 | 57.32 | 57.31 | 57.17 | 56.97 | 56.96 | 56.9 | 56.88 | 56.86 | 56.35 |
| FII | 7.71 | 7.34 | 7.51 | 7.79 | 8.33 | 10.61 | 14.28 | 14.51 | 13.8 | 13.02 |
| DII | 20.22 | 20.64 | 20.79 | 21.23 | 21 | 18.96 | 15.84 | 15.76 | 16.67 | 18.18 |
| Public | 42.67 | 42.68 | 42.69 | 42.83 | 43.03 | 43.04 | 43.1 | 43.12 | 43.14 | 43.65 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 16.88 | 16.88 | 16.88 | 16.84 | 16.78 | 16.78 | 16.78 | 16.77 | 16.77 | 16.62 |
| FII | 2.27 | 2.16 | 2.21 | 2.29 | 2.45 | 3.13 | 4.21 | 4.28 | 4.07 | 3.84 |
| DII | 5.95 | 6.08 | 6.12 | 6.25 | 6.19 | 5.59 | 4.67 | 4.65 | 4.92 | 5.36 |
| Public | 12.56 | 12.57 | 12.57 | 12.62 | 12.68 | 12.68 | 12.71 | 12.72 | 12.73 | 12.88 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 29.44 | 29.44 | 29.45 | 29.45 | 29.46 | 29.46 | 29.48 | 29.49 | 29.5 | 29.5 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.